No quarterly revenue total was found in Greenland Mines Ltd.'s SEC filings.
Greenland Mines Ltd. (GRML) files with the SEC under industry code 2836, Biological Products, (No Diagnostic Substances). Free cash flow was -$7.2 million.
Revenue
—
Net income
$-3.69M
+10.0% vs year-ago quarter
Operating cash flow
$-6.85M
-253.8% vs year-ago quarter
Free cash flow
$-7.17M
EPS
$-0.03
+75.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
158.85M
+158.8% vs year-ago quarter
Net cash
—
Operating margin
—
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- GRML (Nasdaq), GRMLW (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Omaha, NE
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1907223
- Former names
- Klotho Neurosciences, Inc. (until Mar 10, 2026); ANEW Medical, Inc. (until Sep 18, 2024); Redwoods Acquisition Corp. (until Jun 21, 2024)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Operating income | -$5.5M | -$9.5M | -$1.8M | -$1.9M | -$1.9M |
| Net income | -$3.7M | -$13.9M | -$1.3M | -$2.9M | -$4.1M |
| Diluted EPS | -$0.03 | -$0.15 | -$0.02 | -$0.05 | -$0.12 |
| Operating cash flow | -$6.9M | -$5.0M | -$1.3M | -$1.1M | -$1.9M |
| Free cash flow | -$7.2M | — | — | — | — |
| Total assets | $65.0M | $59.7M | $9.6M | $10.1M | $10.8M |
| Total liabilities | $7.1M | $8.3M | $129,764 | $145,891 | $195,409 |
| Stockholders' equity | $57.9M | $51.5M | $9.5M | $9.9M | $10.7M |
| Cash and investments | $9.3M | $10.0M | $7.2M | $7.3M | $8.4M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 2, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 28, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 23, 2026 | Sep 21, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Bylaw or fiscal year change, Shareholder vote results
|
Sep 4, 2026 | Sep 1, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Aug 27, 2026 | Aug 26, 2026 |
All 268 Greenland Mines Ltd. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.